Administration of Carboplatin

Standard Administration Guidelines

• In standard chemotherapy regimens for ovarian cancer, carboplatin is commonly administered over 1 hour when given at AUC 5-6, according to the National Comprehensive Cancer Network, with a strength of evidence based on clinical practice guidelines 1, 2
• For weekly regimens, carboplatin at AUC 2 is administered over 30 minutes, as recommended by the National Comprehensive Cancer Network 1

Important Precautions

• Patients with prior exposure to platinum compounds are at higher risk for hypersensitivity reactions, particularly after cycle 7, with a risk of 27-46%, as reported by the Journal of Allergy and Clinical Immunology 3
• Monitor for hypersensitivity reactions, which occur in 1-30% of patients receiving carboplatin, according to the Journal of Allergy and Clinical Immunology 3

Monitoring During Administration

• Observe for signs of hypersensitivity reactions, which typically occur within minutes or during the infusion, as noted by the Journal of Allergy and Clinical Immunology 3

Special Situations

• For patients with mild hypersensitivity symptoms or heightened anxiety about administration, premedications and slowed infusion rates may be used without formal desensitization, as suggested by the Journal of Allergy and Clinical Immunology 3